Details
Ingredients, MAL, Manufacturer
-
Active Ingredients: Each capsule contains Indacaterol Acetate 150 mcg, Glycopyrronium Bromide 50 mcg, and Mometasone Furoate 160 mcg.
-
Marketing Authorisation (MAL): MAL20050297AZ.
-
Manufacturer: Siegfried Barbera, S.L., Spain.
Content
-
Active Ingredients per Capsule:
-
Indacaterol acetate: 150 mcg
-
Glycopyrronium bromide: 50 mcg
-
Mometasone furoate: 160 mcg
-
-
Formulation: Powder for inhalation in hard capsules.
-
Pack Size: 30 capsules per pack, each accompanied by a Breezhaler inhaler.
Indications
Enerzair Breezhaler is indicated for the maintenance treatment of asthma in adults:
-
Not adequately controlled with a maintenance combination of a long-acting β₂-agonist (LABA) and a high-dose inhaled corticosteroid (ICS), and who have experienced at least one asthma exacerbation in the previous year.
Instructions
Dosage:
-
Inhale the contents of one capsule daily, using the provided Breezhaler inhaler.
-
Administer at the same time each day to maintain consistent symptom control.
Administration:
-
Remove a capsule from the blister pack immediately before use.
-
Insert the capsule into the Breezhaler inhaler.
-
Pierce the capsule by pressing both side buttons simultaneously.
-
Inhale deeply and steadily through the mouthpiece.
-
Hold your breath for up to 5 seconds, then exhale gently.
-
Rinse your mouth with water and spit it out after each use to reduce the risk of oral thrush.
Storage:
-
Store capsules in the original blister pack to protect from moisture and light.
-
Keep the inhaler and capsules in a dry place below 30°C.
-
Keep out of reach of children.
View more about Enerzair Breezhaler - 30's on main site